INCOME STATEMENT
Marksans Pharma Ltd.
BSE
Jun 02, 03:54
255.20
-6.35 ( -2.43%)
Volume
117507
Prev. Close
261.55
Open Price
261.30
Bid Price(Qty.)
255.50 (215)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 02, 03:44
255.15
-6.27 ( -2.40%)
Volume
702514
Prev. Close
261.42
Open Price
260.00
Bid Price(Qty.)
255.15 (700)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE750C01026
|
Market Cap. ( ₹ in Cr. )
|
11562.47
|
P/BV
|
5.07
|
Book Value ( ₹ )
|
50.34
|
|
BSE Code
|
524404
|
52 Week High/Low ( ₹ )
|
359/130
|
FV/ML
|
1/1
|
P/E(X)
|
30.38
|
|
NSE Code
|
MARKSANSEQ
|
Book Closure
|
17/09/2024
|
EPS ( ₹ )
|
8.40
|
Div Yield (%)
|
0.31
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1174.37 | 850.06 | 652.68 | 647.57 | 591.74 |
| Other Operating Revenues | 0.00 | 3.21 | 2.52 | 10.72 | 7.81 |
| Total Operating Revenues | 1174.37 | 853.27 | 655.20 | 658.29 | 599.55 |
| | | | | | |
| Other Income | 69.83 | 62.07 | 60.48 | 42.25 | 31.16 |
| Total Revenue | 1244.21 | 915.35 | 715.69 | 700.54 | 630.70 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 537.18 | 407.15 | 338.49 | 327.99 | 291.29 |
| Purchase Of Stock-In Trade | 102.06 | 79.03 | 66.15 | 45.71 | 46.07 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.70 | -7.25 | -10.19 | 3.89 | 0.55 |
| Employee Benefit Expenses | 101.68 | 77.19 | 56.09 | 60.46 | 54.64 |
| Finance Costs | 1.17 | 0.99 | 3.61 | 3.80 | 5.34 |
| Depreciation And Amortisation Expenses | 29.45 | 29.13 | 16.74 | 17.66 | 15.19 |
| Other Expenses | 228.71 | 157.21 | 112.76 | 106.52 | 93.28 |
| Total Expenses | 1000.95 | 743.45 | 583.65 | 566.03 | 506.37 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 243.26 | 171.89 | 132.04 | 134.51 | 124.33 |
| | | | | | |
| Profit/Loss Before Tax | 243.26 | 171.89 | 132.04 | 134.51 | 124.33 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 54.99 | 37.01 | 30.35 | 30.01 | 28.19 |
| Deferred Tax | 0.00 | 0.68 | -0.17 | 0.50 | -2.24 |
| Tax For Earlier Years | 0.00 | 0.45 | -1.01 | 0.01 | 0.00 |
| Total Tax Expenses | 54.99 | 38.13 | 29.17 | 30.52 | 25.95 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 188.27 | 133.76 | 102.87 | 103.99 | 98.38 |
| | | | | | |
| Profit/Loss From Continuing Operations | 188.27 | 133.76 | 102.87 | 103.99 | 98.38 |
| | | | | | |
| Profit/Loss For The Period | 188.27 | 133.76 | 102.87 | 103.99 | 98.38 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 4.15 | 2.95 | 2.48 | 2.54 | 2.40 |
| Diluted EPS (Rs.) | 4.15 | 2.95 | 2.48 | 2.54 | 2.40 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 22.66 | 10.17 | 10.23 | 4.09 |
| Equity Dividend Rate (%) | 80.00 | 60.00 | 50.00 | 25.00 | 25.00 |